DE69322960T2 - Empfängnisverhütender impfstoff - Google Patents

Empfängnisverhütender impfstoff

Info

Publication number
DE69322960T2
DE69322960T2 DE69322960T DE69322960T DE69322960T2 DE 69322960 T2 DE69322960 T2 DE 69322960T2 DE 69322960 T DE69322960 T DE 69322960T DE 69322960 T DE69322960 T DE 69322960T DE 69322960 T2 DE69322960 T2 DE 69322960T2
Authority
DE
Germany
Prior art keywords
methods
sperm
conceptible
vaccine
sperm surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69322960T
Other languages
English (en)
Other versions
DE69322960D1 (de
Inventor
Paul Primakoff
Diana Myles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Connecticut
Original Assignee
University of Connecticut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Connecticut filed Critical University of Connecticut
Application granted granted Critical
Publication of DE69322960D1 publication Critical patent/DE69322960D1/de
Publication of DE69322960T2 publication Critical patent/DE69322960T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69322960T 1992-06-12 1993-06-10 Empfängnisverhütender impfstoff Expired - Fee Related DE69322960T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89788392A 1992-06-12 1992-06-12
PCT/US1993/005640 WO1993025233A1 (en) 1992-06-12 1993-06-10 Contraceptive vaccine

Publications (2)

Publication Number Publication Date
DE69322960D1 DE69322960D1 (de) 1999-02-18
DE69322960T2 true DE69322960T2 (de) 1999-08-12

Family

ID=25408584

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69322960T Expired - Fee Related DE69322960T2 (de) 1992-06-12 1993-06-10 Empfängnisverhütender impfstoff

Country Status (8)

Country Link
EP (1) EP0646015B1 (de)
JP (1) JPH08503601A (de)
KR (1) KR950701821A (de)
AT (1) ATE175357T1 (de)
AU (1) AU4534893A (de)
CA (1) CA2137077A1 (de)
DE (1) DE69322960T2 (de)
WO (1) WO1993025233A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693496A (en) * 1994-06-20 1997-12-02 Merck & Co., Inc. DNA encoding the mouse and human PH30 beta chain protein
AU3362895A (en) * 1994-08-11 1996-03-07 Duke University Use of zrk peptide sequences in contraception
US8158366B2 (en) * 2008-04-07 2012-04-17 Auburn University Methods of identifying peptides and compositions that bind to oocytes in a species-specific manner

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721348A (en) * 1990-12-14 1998-02-24 University Of Connecticut DNA encoding PH-20 proteins
WO1993006859A1 (en) * 1991-10-04 1993-04-15 The Trustees Of Princeton University Sperm surface protein

Also Published As

Publication number Publication date
ATE175357T1 (de) 1999-01-15
EP0646015B1 (de) 1999-01-07
EP0646015A1 (de) 1995-04-05
CA2137077A1 (en) 1993-12-23
WO1993025233A1 (en) 1993-12-23
JPH08503601A (ja) 1996-04-23
DE69322960D1 (de) 1999-02-18
KR950701821A (ko) 1995-05-17
AU4534893A (en) 1994-01-04

Similar Documents

Publication Publication Date Title
CO4850562A1 (es) Proceso para producir una preparacion concentrada de anticuerpos
CA2103887A1 (en) Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
ATE277633T1 (de) Präparate und verfahren zum auslösen von ctl- immunität
ES2141750T5 (es) Composicion que contiene a la vez una forma soluble y una forma insoluble de un inmunogeno.
FI944676A0 (fi) Rokotteita, jotka sisältävät ionisoitumattomia pinta-aktiivisten aineiden vesikkeleitä
DE69418699D1 (de) Induktion der antworten zytotoxischer t-lymphozyten
HUP0202796A2 (en) Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
DK0561907T3 (da) Proteiner med ændrede epitoper og fremgangsmåder til fremstilling deraf
CA2123580A1 (en) Antigen of hybrid m protein and carrier for group a streptococcal vaccine
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
PT97159A (pt) Processo para a preparacao de uma proteina do antigenio de superficie da hepatite b ou de um seu fragmento e processo para a preparacao de uma vacina
YU48250B (sh) Postupak za pripremanje aktivne vakcine protiv lajmske bolesti
TR199801722T2 (xx) Peptit imm�nojenler.
GB2255093A (en) Hiv-1 core protein fragments
Heath et al. Conjugation of interferon-gamma to antigen enhances its adjuvanticity.
EA199900067A1 (ru) Очищенный поверхностный антиген сперматозоидов, моноклональное антитело для него и их применения
ES2194836T3 (es) Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana.
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
EP2057999A3 (de) Verwendung von immunokonjugaten zur erhöhung der effektivität von mehrstufigen kaskaden-impfstoffen
EP0252064A3 (en) Preparations active against pseudomonas aeruginosa infections, and process for their preparation
DE69322960D1 (de) Empfängnisverhütender impfstoff
DE3585370D1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
ES2060695T3 (es) Concentrados terapeuticos de igm.
EP0320866A3 (de) Schützendes immundominantes Epitop in der S1-Untereinheit von Pertussistoxin
PT636030E (pt) Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee